Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tomokazu Oyama
Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients With Hypertension
Journal of Atherosclerosis and Thrombosis
Biochemistry
Internal Medicine
Cardiovascular Medicine
Cardiology
The Effect of Celiprolol Hydrochloride for Lipid Metabolism. Especially for the Low Density Lipoprotein Particle Size.
Japanese Journal of Geriatrics
Gerontology
Geriatrics
Related publications
Additive Antioxidative Effects of Azelnidipine on Angiotensin Receptor Blocker Olmesartan Treatment for Type 2 Diabetic Patients With Albuminuria
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
The Angiotensin II Type 1 Receptor Blocker Olmesartan Preferentially Improves Nocturnal Hypertension and Proteinuria in Chronic Kidney Disease
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Angiotensin II Receptor Blocker Prevents Increased Arterial Stiffness in Patients With Essential Hypertension
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
The Lack of Benefit of a Combination of an Angiotensin Receptor Blocker and Calcium Channel Blocker on Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease
Renal Failure
Medicine
Nephrology
Critical Care
Intensive Care Medicine
Renoprotective Effects of an Angiotensin II Receptor Blocker in Experimental Model Rats With Hypertension and Metabolic Disorders
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Angiotensin II Receptor Blocker and Long-Acting Calcium Channel Blocker Combination Therapy Decreases Urinary Albumin Excretion While Maintaining Glomerular Filtration Rate
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Age-Related Difference in the Sleep Pressure-Lowering Effect Between an Angiotensin II Receptor Blocker and a Calcium Channel Blocker in Asian Hypertensives: The ACS1 Study
Hypertension
Internal Medicine
A Different Dihydropyridine Calcium Channel Blocker in Hypertensive Patients Who Developed Pedal Edema on Dihydropyridine Calcium Channel Blocker Therapy
Cumhuriyet Medical Journal
Medicine
Olmesartan Medoxomil, an Angiotensin II Receptor Blocker Ameliorates Insulin Resistance and Decreases Triglyceride Production in Fructose-Fed Rats
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology